Investor FAQ

  • On December 21, 1993, M & N Capital Corp. ("M & N"), a New York corporation, completed a reverse acquisition with Analytical Nursing Management Corporation ("ANMC"), a Louisiana corporation, and began trading on the OTC bulletin board. M & N had no business operations. It was established as a "blind pool" of investors and registered as a public corporation with the Securities and Exchange Commission. Through the acquisition, ANMC became a wholly-owned subsidiary of M & N and received a capital injection of $1.265 million. In July 1994, M & N moved its state of incorporation from New York to Delaware and changed its name to Analytical Nursing Management Corporation. On August 17, 1994, ANMC started trading on the NASDAQ Small Cap Market. In August 1995, the Company changed its name to Amedisys, Inc. ("AMEDISYS").
  • Amedisys has had two follow-on public offerings of its common stock. The first was completed on September 28, 2004, when 2,460,000 shares of Amedisys common stock were sold at a per common share price of $27.50.

    The second was completed on November 22, 2006, when 3,000,000 shares of Amedisys common stock were sold at a per common share price of $41.50.

  • The ticker symbol is AMED.
  • The company’s shares trade on the NASDAQ Global Select Market (“NASDAQ”).
  • Amedisys common stock can be bought or sold through a stock broker or bank, or generally through a financial institution that provides brokerage services.
  • No, we currently do not offer a direct purchase plan to non-employees.
  • Currently, Amedisys does not issue dividends or have a DRIP plan.
  • All requests for address and title changes for Amedisys stock should be addressed to our transfer agent American Stock Transfer Shareholder Services
    59 Maiden Lane, Plaza Level
    New York, New York 10038
    (718) 921-8293
  • On October 25, 2006, Amedisys announced a four-for-three stock split in the form of a 33 1/3 stock dividend that was paid on December 4, 2006 to holders of record as of November 27, 2006.
  • Amedisys’ fiscal year ends in December 31, with quarters ending March 31, June 30, September 30, and December 31.
  • Amedisys independent accountants are KPMG LLP based in Baton Rouge, Louisiana.
  • Visit the Financial Reports page to review the latest Annual Report and Proxy Statement online. For SEC filings, please visit the SEC Filings page If you require hard copies of any materials you may submit a request through the Contact Form.
  • To review a full list of our financial analysts, please visit our Analyst Coverage page.
  • Amedisys was incorporated in 1982 in Louisiana. In 1993, the Company became public through a merger with M & N Capital, a New York corporation. In 1994, it moved its state of incorporation from New York to Delaware.

Contact Information

Amedisys Corporate Headquarters
3854 American Way
Baton Rouge, LA 70816
(225) 292-2031
Amedisys Executive Office
209 10th Avenue S.
Suite 512
Nashville, TN 37203
Request Information
^
To Top